Retraction Note Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. May 27, 2025; 17(5): 105113
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.105113
Retraction note: Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy
Rui Feng, De-Xin Cheng, Department of Interventional Medicine, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Tao Song, Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Long Chen, Department of Radiotherapy, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Kai-Ping Lu, Department of Vascular Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
ORCID number: Rui Feng (0000-0001-8757-2607); Kai-Ping Lu (0000-0002-0578-4567).
Author contributions: All authors have read and agreed to the published version of the retraction note.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kai-Ping Lu, Associate Chief Physician, Department of Vascular Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Gongshu District, Hangzhou 310000, Zhejiang Province, China. lukaiping158@126.com
Received: January 12, 2025
Revised: March 4, 2025
Accepted: April 1, 2025
Published online: May 27, 2025
Processing time: 131 Days and 18.8 Hours

Abstract

The retraction note addresses allegations concerning the published article titled “Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy”. World J Gastrointest Surg 2023; 15: 687-697. To preserve academic integrity and avoid misleading the readers, the authors agreed to retract the article, due to significant concerns regarding the reliability of the transarterial radioembolization data obtained by exploratory, non-standardized interventional procedures and ethical compliance in this study, which severely damaged the conclusion in this study. The authors sincerely apologize to the readers, reviewers and editors for these errors and for any inconvenience caused by this retraction.

Key Words: World Journal of Gastrointestinal Surgery; Retraction note

Core Tip: This retraction note addresses concerns regarding the article "Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy". Due to the significant concerns of the reliability of the data classification and ethical compliance in this study, the authors decided to withdraw the manuscript and sincerely apologize to the readers, reviewers and editors for these errors and for any inconvenience caused by this retraction.



RETRACTION NOTE

We have thoroughly reviewed the allegations regarding our published article, titled "Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy," published in World Journal of Gastrointestinal Surgery (Vol. 15, Issue 4, 2023)[1].

We fully recognize the significant concerns regarding the timeline discrepancy of the transarterial radioembolization (TARE) procedure in China and the authenticity of the submitted ethical approval documents. After conducting an internal review and engaging in discussions with the relevant hospital ethics committee, we would like to offer the following clarifications and decisions.

TIMELINE OF TARE PROCEDURE IMPLEMENTATION

Concerning the timeline discrepancy of TARE procedure described in the article (2016-2021) and its actual introduction in China (2022), we acknowledge that ambiguity in the procedural definitions and timelines may lead to misunderstandings about the clinical application of TARE mentioned in the study. Upon careful re-examination, the term “TARE” in this study encompassed exploratory, non-standardized interventional procedures conducted prior to the formal adoption of TARE technology in China (2022). Consequently, the data cannot be reliably attributed to the current standardized TARE protocol and the conclusions drawn from this cohort are not that valid. We deeply regret this omission and take full responsibility for the confusion it has caused.

ETHICAL APPROVAL DOCUMENT ISSUES

With regard to the concerns about the ethical approval documents, we accept full responsibility for the errors and potential irregularities found in these documents. These issues likely arose due to technical errors during the organization and submission of the materials, or due to discrepancies in file transfers. While the study was conducted in accordance with ethical principles, the inability to provide complete and verifiable documentation necessitates retraction to uphold the highest standards of research integrity.

DECISION TO WITHDRAW THE ARTICLE

While we remain confident in the scientific rigor underlying the research, we recognize that the current situation could adversely impact the academic reputation of both the authors and the journal. To prevent further misunderstandings and avoid unnecessary disputes, we have decided to withdraw the manuscript. This decision is made in the interest of preserving the integrity of the academic process and maintaining a transparent and credible research environment.

Should additional information or documentation be required, we are fully prepared to cooperate and provide the necessary materials. Please do not hesitate to contact us if further actions are needed on our part.

Thank you for your understanding and continued support in upholding the integrity of scientific research.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade A, Grade A, Grade C, Grade D

Novelty: Grade A, Grade A, Grade C, Grade D

Creativity or Innovation: Grade A, Grade A, Grade C, Grade D

Scientific Significance: Grade A, Grade A, Grade C, Grade D

P-Reviewer: Dragoteanu MN; Harmanci O; Hashimoto N S-Editor: Li L L-Editor: A P-Editor: Yu HG

References
1.  Feng R, Cheng DX, Song T, Chen L, Lu KP. Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy. World J Gastrointest Surg. 2023;15:687-697.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]